Yifeng Pharmacy Chain Co (603939.SS) Stock Price

Yifeng Pharmacy Chain Co Price

🇨🇳SSE·CLOSED
21.13CNY
Market closed
Today +/-
Today %

Yifeng Pharmacy Chain Co (603939.SS) Stock | ISIN CNE100001TS5. The current Yifeng Pharmacy Chain Co stock price is 21.13 CNY (2026). Revenue is 27.02 B CNY. Net income is 2.02 B CNY. The P/E ratio is 12.92. Market capitalization is 26.05 B CNY. Yifeng Pharmacy Chain Co operates in the Non-cyclical consumption sector.

Yifeng Pharmacy Chain Co stock price

Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Yifeng Pharmacy Chain Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Yifeng Pharmacy Chain Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Yifeng Pharmacy Chain Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Yifeng Pharmacy Chain Co Stock Price History
DateYifeng Pharmacy Chain Co Price
Access this data via the Eulerpool API
Get Free API Key

Yifeng Pharmacy Chain Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2012
1.54 B CNY
87 M CNY
69 M CNY
Jan 1, 2013
1.8 B CNY
128 M CNY
99 M CNY
Jan 1, 2014
2.23 B CNY
178 M CNY
141 M CNY
Jan 1, 2015
2.85 B CNY
204 M CNY
176 M CNY
Jan 1, 2016
3.73 B CNY
265 M CNY
224 M CNY
Jan 1, 2017
4.81 B CNY
377 M CNY
314 M CNY
Jan 1, 2018
6.91 B CNY
514 M CNY
416 M CNY
Jan 1, 2019
10.28 B CNY
828 M CNY
544 M CNY
Jan 1, 2020
13.15 B CNY
1.16 B CNY
768 M CNY
Jan 1, 2021
15.33 B CNY
1.4 B CNY
887.88 M CNY
Jan 1, 2022
19.89 B CNY
1.95 B CNY
1.27 B CNY
Jan 1, 2023
22.59 B CNY
2.04 B CNY
1.41 B CNY
Jan 1, 2024
24.06 B CNY
2.21 B CNY
1.53 B CNY
Invalid Date
24.77 B CNY
2.56 B CNY
1.75 B CNY
Invalid Date
27.02 B CNY
2.88 B CNY
2.02 B CNY

Yifeng Pharmacy Chain Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 10, 2026, 5:55 PM
 
REVENUE (M CNY)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M CNY)
NET INCOME (M CNY)
NET INCOME GROWTH (%)
DIV. (CNY)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Yifeng Pharmacy Chain Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Yifeng Pharmacy Chain Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Yifeng Pharmacy Chain Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Yifeng Pharmacy Chain Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Yifeng Pharmacy Chain Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Yifeng Pharmacy Chain Co stock margins

The Yifeng Pharmacy Chain Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Yifeng Pharmacy Chain Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Yifeng Pharmacy Chain Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2012
37.04 %
5.65 %
4.48 %
Jan 1, 2013
38.41 %
7.1 %
5.49 %
Jan 1, 2014
39.51 %
7.98 %
6.32 %
Jan 1, 2015
38.9 %
7.17 %
6.18 %
Jan 1, 2016
39.39 %
7.1 %
6 %
Jan 1, 2017
39.86 %
7.84 %
6.53 %
Jan 1, 2018
38.9 %
7.44 %
6.02 %
Jan 1, 2019
38.85 %
8.06 %
5.29 %
Jan 1, 2020
37.74 %
8.82 %
5.84 %
Jan 1, 2021
40.08 %
9.15 %
5.79 %
Jan 1, 2022
39.25 %
9.79 %
6.36 %
Jan 1, 2023
37.89 %
9.02 %
6.25 %
Jan 1, 2024
39.77 %
9.2 %
6.35 %
Invalid Date
39.77 %
10.35 %
7.06 %
Invalid Date
39.77 %
10.65 %
7.46 %

Yifeng Pharmacy Chain Co Stock Revenue, EBIT, Earnings per Share

The Yifeng Pharmacy Chain Co earnings per share therefore indicates how much revenue Yifeng Pharmacy Chain Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2012
3.52 CNY
0.2 CNY
0.16 CNY
Jan 1, 2013
4.13 CNY
0.29 CNY
0.23 CNY
Jan 1, 2014
5.1 CNY
0.41 CNY
0.32 CNY
Jan 1, 2015
4.89 CNY
0.35 CNY
0.3 CNY
Jan 1, 2016
5.66 CNY
0.4 CNY
0.34 CNY
Jan 1, 2017
7.28 CNY
0.57 CNY
0.48 CNY
Jan 1, 2018
10.44 CNY
0.78 CNY
0.63 CNY
Jan 1, 2019
14.98 CNY
1.21 CNY
0.79 CNY
Jan 1, 2020
19.16 CNY
1.69 CNY
1.12 CNY
Jan 1, 2021
12.74 CNY
1.17 CNY
0.74 CNY
Jan 1, 2022
16.47 CNY
1.61 CNY
1.05 CNY
Jan 1, 2023
18.63 CNY
1.68 CNY
1.16 CNY
Jan 1, 2024
19.52 CNY
1.8 CNY
1.24 CNY
Invalid Date
20.09 CNY
2.08 CNY
1.42 CNY
Invalid Date
21.92 CNY
2.33 CNY
1.64 CNY

Yifeng Pharmacy Chain Co business model & stock analysis

Yifeng Pharmacy Chain Co., Ltd. engages in the chain retailing of pharmaceuticals, health products, medical equipment and health-related household convenience products. The company is headquartered in Changsha, Hunan and currently employs 35,915 full-time employees. The company went IPO on 2015-02-17. The firm mainly operates through retailing segment. The firm operates more than 1, 000 direct pharmaceutical chain stores mainly in six provinces (or municipalities), including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang and Jiangxi. The retail products of the Company includes pharmaceuticals, medical equipment, health products, health food, personal care products and maternal and child products. The firm is also engaged in the wholesale business through its subsidiary, Hunan Yifeng Pharmaceutical Co., Ltd.

Yifeng Pharmacy Chain Co Eulerpool Fair Value

Yifeng Pharmacy Chain Co historical P/E ratio, EBIT multiple, and P/S ratio

Yifeng Pharmacy Chain Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Yifeng Pharmacy Chain Co shares outstanding

The number of shares was Yifeng Pharmacy Chain Co in 2025 — This indicates how many shares 1.233 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2012
437 M base_Shares
Jan 1, 2013
437 M base_Shares
Jan 1, 2014
437 M base_Shares
Jan 1, 2015
582 M base_Shares
Jan 1, 2016
660 M base_Shares
Jan 1, 2017
660 M base_Shares
Jan 1, 2018
662 M base_Shares
Jan 1, 2019
686 M base_Shares
Jan 1, 2020
686 M base_Shares
Jan 1, 2021
1.2 B base_Shares
Jan 1, 2022
1.21 B base_Shares
Jan 1, 2023
1.21 B base_Shares
Jan 1, 2024
1.23 B base_Shares
Invalid Date
1.23 B base_Shares
Invalid Date
1.23 B base_Shares

Yifeng Pharmacy Chain Co Dividend History

10 years of dividend payments · 2 consecutive increases

YearAnnual DividendYoY ChangePayments
20250.7CNY↑ 5.0%2×
Jun 18, 20250.4CNY↑ 60.0%1/2
Sep 17, 20250.3CNY↓ 25.0%2/2
20240.67CNY↑ 133.3%2×
20230.29CNY↓ 4.8%1×
20220.3CNY↑ 30.0%1×
20210.23CNY↑ 7.7%1×
20200.21CNY↓ 28.6%1×
20190.3CNY 0.0%1×
20180.3CNY 0.0%1×
20170.3CNY↑ 20.0%1×
20150.25CNY—1×

Yifeng Pharmacy Chain Co dividend history and estimates

In 2025, Yifeng Pharmacy Chain Co paid a dividend amounting to 0.7 CNY. Dividend means that Yifeng Pharmacy Chain Co distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Invalid Date
0.25 CNY
-0.09 CNY
Invalid Date
0.3 CNY
-0.1 CNY
Jan 1, 2018
0.3 CNY
0 CNY
Jan 1, 2019
0.3 CNY
0 CNY
Jan 1, 2020
0.21 CNY
0 CNY
Jan 1, 2021
0.23 CNY
0 CNY
Jan 1, 2022
0.3 CNY
0 CNY
Jan 1, 2023
0.29 CNY
0 CNY
Jan 1, 2024
0.67 CNY
0 CNY
Jan 1, 2025
0.7 CNY
0 CNY
Invalid Date
0 CNY
0.26 CNY
Invalid Date
0 CNY
0.3 CNY

Yifeng Pharmacy Chain Co dividend payout ratio

In 2025, Yifeng Pharmacy Chain Co had a payout ratio of 16.22%. The payout ratio indicates the percentage of the company's profits that Yifeng Pharmacy Chain Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2012
14.8 %
Jan 1, 2013
14.8 %
Jan 1, 2014
14.8 %
Jan 1, 2015
27.27 %
Jan 1, 2016
14.8 %
Jan 1, 2017
20.87 %
Jan 1, 2018
15.57 %
Jan 1, 2019
12.42 %
Jan 1, 2020
8.76 %
Jan 1, 2021
18.62 %
Jan 1, 2022
17.04 %
Jan 1, 2023
14.8 %
Jan 1, 2024
16.82 %
Invalid Date
16.22 %
Invalid Date
15.95 %
Price targets and forecasts for Yifeng Pharmacy Chain Co are not yet available.

EESG©

Eulerpool ESG Scorecard© for the Yifeng Pharmacy Chain Co stock

49/100
32
Environment
47
Social
70
Governance
E

Environment

20
Scope 1 - Direct Emissions1,082.09
Scope 2 - Indirect emissions from purchased energy111,325.27
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions112,407.36
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees86.264
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Yifeng Pharmacy Chain Co shareholder structure

% Name
19.55191%
Ningbo Meishan Bonded Port Area Houxin Venture Capital Partnership LP
Ningbo Meishan Bonded Port Area Houxin Venture Capital Partnership LP
11.47713%
Gao (Yi)
Gao (Yi)
9.45316%
Capital Today Investment XV (HK) Ltd.
Capital Today Investment XV (HK) Ltd.
9.39958%
Capital Today Investment XIV (HK) Ltd.
Capital Today Investment XIV (HK) Ltd.
1.62769%
Harvest Fund Management Co., Ltd.
Harvest Fund Management Co., Ltd.
1.18899%
Zhong Ou Asset Management Co., Ltd.
Zhong Ou Asset Management Co., Ltd.
1.18344%
Norges Bank Investment Management (NBIM)
Norges Bank Investment Management (NBIM)
1.06444%
FIL Investment Management (Singapore) Ltd.
FIL Investment Management (Singapore) Ltd.
0.98728%
Stewart Investors
Stewart Investors
0.89666%
Baillie Gifford & Co.
Baillie Gifford & Co.
...

Yifeng Pharmacy Chain Co Executives and Management Board

YG

Mr. Yi Gao

(56)

Chairman of the Board, President · since 2021

Compensation2.88 M CNY
YG

Mr. Youcheng Gao

(57)

Executive President, Staff Elected Director · since 2021

Compensation2.54 M CNY
YW

Mr. Yonghui Wang

(48)

Finance Director, Vice President

Compensation2.29 M CNY
ZZ

Mr. Zhaoxu Zhang

(51)

Vice President

Compensation2.08 M CNY
JY

Mr. Jun Yan

(43)

Assistant President, General Manager - New Retail Business Division

Compensation1.94 M CNY

Frequently asked questions about Yifeng Pharmacy Chain Co

All fundamentals and in-depth analysis of Yifeng Pharmacy Chain Co

Our stock analysis for Yifeng Pharmacy Chain Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yifeng Pharmacy Chain Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co Revenue→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co Net Income→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co P/E→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co P/S→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co EBIT→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co Dividend→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co Directors Dealings→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co Stocks→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co Market capitalization→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co Debt→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co Liabilities→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co Equity→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co AAQS→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co Employees→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co ROE→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co ROA→
Yifeng Pharmacy Chain Co Stock
Yifeng Pharmacy Chain Co ROCE→